Fundraising FoxAspiAir GmbH
Gemünden (Wohra), DE · 1 known investors
Find your way into AspiAir GmbH
Sign up to see every warm intro you have to AspiAir GmbH
- Paths you didn't know you had: your email and LinkedIn already hold routes to the AspiAir GmbH team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
AspiAir is a clinical-stage biotech company developing LASAG Inhale, an inhaled non-opioid treatment for pain and migraine attacks using acetylsalicylic acid. The company serves patients in the EU who lack access to adequate migraine medications and aims to provide a safe, mobile alternative to current therapies.
Founders & leadership
DS
Dr. Stefan DegenhardtManaging Director & CFO
DS
Dr. Sebastian CanisiusChief Medical Officer
DK
Dr. Karlheinz NockerProject Manager
Investors · 1
Frequently asked questions
- What does AspiAir GmbH do?
- AspiAir is a clinical-stage biotech company developing LASAG Inhale, an inhaled non-opioid treatment for pain and migraine attacks using acetylsalicylic acid. The company serves patients in the EU who lack access to adequate migraine medications and aims to provide a safe, mobile alternative to current therapies.
- Who are AspiAir GmbH's investors?
- AspiAir GmbH's investors include ATON GmbH.
- Where is AspiAir GmbH headquartered?
- AspiAir GmbH is headquartered in Gemünden (Wohra), DE.